Literature DB >> 26564118

Sensorineural deafness following routine transurethral resection of the prostate.

Benjamin Bowsher1.   

Abstract

A man in his 50s presented to a rural Australian emergency department with complete unilateral hearing loss following transurethral resection of the prostate. His hearing impairment progressed from 'muffled hearing' with tinnitus on emergence from anaesthesia, to total sensorineural deafness by day three. His surgery and anaesthesia were uncomplicated and he had remained normotensive throughout. He had no pre-existing auditory disease. He had received 240 mg of intravenous gentamicin intraoperatively for surgical prophylaxis. Renal function was normal. Brain imaging was negative for structural pathology, stroke and circulatory insufficiency. Ear nose and throat advised 7 days of oral corticosteroids, transtympanic dexamethasone and hyperbaric oxygen therapy. A working diagnosis of gentamicin-induced ototoxicity was applied. Intervention has proven unsuccessful and there is no possibility for rehabilitation. The patient is permanently disabled. 2015 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26564118      PMCID: PMC4654020          DOI: 10.1136/bcr-2015-212933

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  17 in total

1.  A meta-analysis of studies on the safety and efficacy of aminoglycosides given either once daily or as divided doses.

Authors:  W J Munckhof; M L Grayson; J D Turnidge
Journal:  J Antimicrob Chemother       Date:  1996-04       Impact factor: 5.790

2.  Effects of neuroactive steroids on cochlear hair cell death induced by gentamicin.

Authors:  Mariko Nakamagoe; Keiji Tabuchi; Bungo Nishimura; Akira Hara
Journal:  Steroids       Date:  2011-08-12       Impact factor: 2.668

3.  Unilateral vestibular loss due to systemically administered gentamicin.

Authors:  Rebekah M Ahmed; Hamish G MacDougall; G Michael Halmagyi
Journal:  Otol Neurotol       Date:  2011-09       Impact factor: 2.311

Review 4.  The injured cochlea as a target for inflammatory processes, initiation of cell death pathways and application of related otoprotectives strategies.

Authors:  Ralph N Abi-Hachem; Azel Zine; Thomas R Van De Water
Journal:  Recent Pat CNS Drug Discov       Date:  2010-06

5.  Hearing loss in patients with vestibulotoxic reactions to gentamicin therapy.

Authors:  Robert A Dobie; F Owen Black; Susan C Pezsnecker; Valerie L Stallings
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2006-03

6.  Recent advances in understanding aminoglycoside ototoxicity and its prevention.

Authors:  Wei-Jing Wu; Su-Hua Sha; Jochen Schacht
Journal:  Audiol Neurootol       Date:  2002 May-Jun       Impact factor: 1.854

7.  Assessment of nutrient supplement to reduce gentamicin-induced ototoxicity.

Authors:  C G Le Prell; C Ojano-Dirain; E W Rudnick; M A Nelson; S J DeRemer; D M Prieskorn; J M Miller
Journal:  J Assoc Res Otolaryngol       Date:  2014-03-04

8.  Cochlear implantation in patients deafened by ototoxic drugs.

Authors:  Jaya Nichani; Iain A Bruce; Deborah Mawman; Sadie Khwaja; Richard Ramsden; Kevin Green
Journal:  Cochlear Implants Int       Date:  2013-03-18

9.  Genetic susceptibility to aminoglycoside ototoxicity: how many are at risk?

Authors:  Hsiao-Yuan Tang; Eldridge Hutcheson; Susan Neill; Margaret Drummond-Borg; Michael Speer; Raye Lynn Alford
Journal:  Genet Med       Date:  2002 Sep-Oct       Impact factor: 8.822

10.  The effects of hyperbaric oxygen therapy upon ototoxic injuries produced by amikacin in guinea pigs.

Authors:  Luciana de Albuquerque Salviano Amora; Adriana de Andrade Batista Murashima; Maria Rossato; Márcia Bento Moreira; Miguel Ângelo Hyppolito; Djalma José Fagundes
Journal:  Braz J Otorhinolaryngol       Date:  2013 May-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.